The Use of Psychedelic Medicines to Treat Resistant Post Traumatic Stress Disorder: The Legal and Policy Implications

Nash, Jonathan (2017) The Use of Psychedelic Medicines to Treat Resistant Post Traumatic Stress Disorder: The Legal and Policy Implications. In: EMDR Association UK & Ireland Annual Conference 2017, 24th - 25th March 2017, London.

[img] Slideshow (Powerpoint)
EMDR.pptx - Published Version
Restricted to Registered users only

Download (5MB) | Request a copy
[img] Text (Slideshow)
EMDR (1).pdf - Published Version
Restricted to Registered users only

Download (2MB) | Request a copy

Abstract

Psychedelic research into psychiatric disorders is slowly re-emerging after a near 40-year morass. The presentation touches on psychedelic research history, its near-complete prohibition from the early 1970s and recent rebirth. Current US trials of MDMA-assisted psychotherapy and medical marijuana for treatment-resistant PTSD are focussed on as are patent applications for nasal ketamine sprays for the acutely suicidal. The laws and regulatory procedures governing current clinical research and likely future licensing are considered.

Item Type: Conference or Workshop Item (Lecture)
Uncontrolled Keywords: PTSD, psychedelic medicines, legal and policy implications
Subjects: B200 Pharmacology, Toxicology and Pharmacy
M200 Law by Topic
Department: Faculties > Business and Law > Northumbria Law School
Depositing User: Jonathan Nash
Date Deposited: 04 Sep 2017 09:42
Last Modified: 22 Dec 2017 19:58
URI: http://nrl.northumbria.ac.uk/id/eprint/31695

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics


Policies: NRL Policies | NRL University Deposit Policy | NRL Deposit Licence